COVID-19 and Alzheimer’s disease: how one crisis worsens the other
Abstract Alzheimer’s disease (AD) has emerged as a key comorbidity of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The morbidity and mortality of COVID-19 are elevated in AD due to multiple pathological changes in AD patients such as the...
Main Authors: | Xiaohuan Xia, Yi Wang, Jialin Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | Translational Neurodegeneration |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40035-021-00237-2 |
Similar Items
-
Regulated upon activation, normal T cell expressed and secreted (RANTES) levels in the peripheral blood of patients with Alzheimer’s disease
by: Gabriela Vacinova, et al.
Published: (2021-01-01) -
COVID-19 and Alzheimer’s Disease
by: Marcello Ciaccio, et al.
Published: (2021-02-01) -
Delirium Severely Worsens Outcome in Patients with COVID-19—A Retrospective Cohort Study from Temporary Critical Care Hospitals
by: Katarzyna Kotfis, et al.
Published: (2021-07-01) -
Determining the relationship between SARS-CoV-2 infection, dopamine, and COVID-19 complications
by: Muad M. Khalefah, Master of Science in Medicine, et al.
Published: (2020-12-01) -
SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects
by: Orianne Constant, et al.
Published: (2021-07-01)